Functional subsets of mouse natural killer cells (Q36652157)

15 August 2017

1 reference

title

Functional subsets of mouse natural killer cells (English)

1 reference

15 August 2017

Stephen L Nutt

3

0 references

Mark J. Smyth

object named as

Mark J Smyth

series ordinal

4

0 references

author name string

Yoshihiro Hayakawa

series ordinal

1

1 reference

PubMed ID

17100875

15 August 2017

Nicholas D Huntington

series ordinal

2

1 reference

15 August 2017

1 December 2006

1 reference

15 August 2017

Immunological Reviews

1 reference

15 August 2017

214

1 reference

15 August 2017

47-55

1 reference

The biology of human natural killer-cell subsets

15 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

What does it take to make a natural killer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

The dynamic life of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

Development and tolerance of natural killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

Peripheral NK cell phenotypes: multiple changing of faces of an adapting, developing cell.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

Commitment to natural killer cells requires the helix-loop-helix inhibitor Id2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

Identification of committed NK cell progenitors in adult murine bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

In vivo developmental stages in murine natural killer cell maturation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

TNF/TNFR family members in costimulation of T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

Failing immune control as a result of impaired CD8+ T-cell maturation: CD27 might provide a clue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

Antigen-specific memory B cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

CD27: marker and mediator of T-cell activation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

In search of the 'missing self': MHC molecules and NK cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

Cutting edge: identification of E-cadherin as a ligand for the murine killer cell lectin-like receptor G1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

Killer cell lectin-like receptor G1 binds three members of the classical cadherin family to inhibit NK cell cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

Natural killer cell developmental pathways: a question of balance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

G protein-coupled receptors in natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

IL-15 alters expression and function of the chemokine receptor CX3CR1 in human NK cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

IL-15 and IL-2 oppositely regulate expression of the chemokine receptor CX3CR1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

Natural killer cells and pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

NK cell TRAIL eliminates immature dendritic cells in vivo and limits dendritic cell vaccination efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

Evidence for discrete stages of human natural killer cell differentiation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

New aspects of natural-killer-cell surveillance and therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

Nature's TRAIL--on a path to cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

TRAIL and its receptors as targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

Constitutive expression of high affinity interleukin 2 receptors on human CD16-natural killer cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

STAT6-dependent differentiation and production of IL-5 and IL-13 in murine NK2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1alpha (MIP-1alpha)-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

An essential role for tumor necrosis factor in natural killer cell-mediated tumor rejection in the peritoneum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

In vivo survival and homeostatic proliferation of natural killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

Turnover and proliferation of NK cells in steady state and lymphopenic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

Absence of interleukin 2 production in a severe combined immunodeficiency disease syndrome with T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

Evaluation of natural killer cell expansion and activation in vivo with daily subcutaneous low-dose interleukin-2 plus periodic intermediate-dose pulsing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

A requirement for CD45 distinguishes Ly49D-mediated cytokine and chemokine production from killing in primary natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

IL-15 is an essential mediator of peripheral NK-cell homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

Requirement for IRF-1 in the microenvironment supporting development of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2006.00454.X

TRAIL identifies immature natural killer cells in newborn mice and adult mouse liver

21 January 2018

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1182/BLOOD-2004-08-3262

Identifiers

DOI

10.1111/J.1600-065X.2006.00454.X

1 reference

15 August 2017

1 reference

PubMed ID

17100875